1. A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome 
Dorte Glintborg, M.D., Ph.D., Anne Pernille Hermann, M.D., Ph.D., Claus Hagen, M.D., Dr.Sci., Lars Thorbjørn Jensen, M.D., Jan Frystyk, M.D., Ph.D., Dr.Sci., Paul Bennett, Ph.D., Allan Flyvbjerg, M.D., Dr.Sci., Marianne Andersen, M.D., Ph.D. 
Fertility and Sterility 
Volume 91, Issue 3, Pages (March 2009)
DOI: /j.fertnstert
Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

2. Figure 1
Scatterplots of correlations between changes in (A) insulin-like growth factor I (IGF-l), (B) peak growth hormone (GH), and (C) adiponectin vs. changes in measures of relative 5α-reductase activity in all PCOS patients (solid line) and during pioglitazone treatment (dashed line). A/E = androsterone/etiocholanolone ratio; THF = tetrahydrocortisol.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions